Rosuvastatin Tablet, Film Coated
Product Images NDC 71610-798

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 71610-798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (71610 0798 15)

Label (71610 0798 15)
Rosuvastatin 40 mg film-coated tablets carton label showing the product name, strength, quantity of 15 tablets, and NDC 71610-0798-15. The label indicates manufacturer Aphena Pharma Solutions - Tennessee, LLC, located in Cookeville, TN. Additional storage and safety instructions are included on the label.*
FDA Label Image

Aphena (Aphena)

Aphena (Aphena)
FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
A cumulative incidence graph comparing Rosuvastatin (Rosuva) and Placebo over a period of 5 years. The graph shows cumulative incidence percentage on the vertical axis and years on the horizontal axis. It includes a hazard ratio (HR) of 0.56 with 95% confidence interval (0.46-0.69) and a p-value less than 0.001. A table below the graph displays the number of subjects at risk for both Rosuvastatin and placebo groups at different time points.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
Data table presenting the number of events and event rates per 1000 patient years comparing Rosuvastatin 20 mg to placebo 20 mg across several cardiovascular endpoints. It includes hazard ratios with 95% confidence intervals and p-values for endpoints like primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. The table is accompanied by a forest plot illustrating hazard ratios and confidence intervals visually.*
FDA Label Image

Figure-02 (Figure 3)

Figure-02 (Figure 3)
A box plot chart depicting the percent change from baseline in LDL-C for four statin medications: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The x-axis shows doses in mg for each drug, while the y-axis shows percent change from 0 to -75. Each drug's dose-effect is displayed with box plots representing variability in LDL-C reduction.*
FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)
Chemical structure of Rosuvastatin Calcium as shown in the image, depicting the molecular components and arrangement, including the calcium ion (Ca2+) complex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.